Transcriptome-scale RNA-targeting CRISPR screens reveal essential lncRNAs in human cells

Cell. 2024 Nov 11:S0092-8674(24)01203-0. doi: 10.1016/j.cell.2024.10.021. Online ahead of print.

Abstract

Mammalian genomes host a diverse array of RNA that includes protein-coding and noncoding transcripts. However, the functional roles of most long noncoding RNAs (lncRNAs) remain elusive. Using RNA-targeting CRISPR-Cas13 screens, we probed how the loss of ∼6,200 lncRNAs impacts cell fitness across five human cell lines and identified 778 lncRNAs with context-specific or broad essentiality. We confirm their essentiality with individual perturbations and find that the majority of essential lncRNAs operate independently of their nearest protein-coding genes. Using transcriptome profiling in single cells, we discover that the loss of essential lncRNAs impairs cell-cycle progression and drives apoptosis. Many essential lncRNAs demonstrate dynamic expression across tissues during development. Using ∼9,000 primary tumors, we pinpoint those lncRNAs whose expression in tumors correlates with survival, yielding new biomarkers and potential therapeutic targets. This transcriptome-wide survey of functional lncRNAs advances our understanding of noncoding transcripts and demonstrates the potential of transcriptome-scale noncoding screens with Cas13.

Keywords: CRISPR-Cas13; MALAT1; MIR17HG; RNA targeting; SLC16A1-AS1; essential genes; human development; lncRNA; noncoding RNA; transcriptome scale; tumor biomarkers.